Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 885 results for "merck co"

Merck inaugurates its new biomass plant in India
Bio Spectrum Asia

Merck inaugurates its new biomass plant in India

Singapore: German drug giant Merck has, today, commissioned a climate-neutral co-generation plant at its production site in Goa, India. The initiative is a part of Merck's company-wide climate protection program. Earlier this year, the drug maker ... Bio Spectrum Asia, 13 hours ago
Merck's biomass power plant commissioned in India Energy Business Review, 13 hours ago

53 images for merck co

Jutia Group, 1 day ago
Drug Discovery and Development, 3 days ago
Yahoo! News, 4 days ago
McDuffieMirror, 2 days ago
Jutia Group, 1 week ago
Zawya.com, 3 weeks ago
Bio Spectrum Asia, 13 hours ago
The Rakyat Post, 2 days ago
Bidness Etc, 1 week ago
Live Trading News, 4 weeks ago

Merck (MRK) Showing Support Near $58.85

The patented options-trade picking algorithms used by MarketIntelligenceCenter.com found a trading opportunity with Merck & Co Inc. (http://www.marketintelligencecenter.com/symbol/MRK"MRK) that should provide a 2.15% return in just 142 days. Sell ...
 Individual.com1 day ago Potential Merck (MRK) Trade Has 5.05% Downside Protection  Individual.com2 days ago Merck (MRK) Showing Bullish Technicals With Support At $58.98  Individual.com3 days ago Potential Merck (MRK) Trade Targets 2.35% Return  Individual.com6 days ago

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs

Summary Last week, a major potential headwind turned into a tailwind for potential "PCSK9 inhibitor" blockbusters from Amgen and Regeneron/Sanofi. The good news was that Merck's IMPROVE-IT cholesterol study supported the "LDL hypothesis" upon ...
 Seeking Alpha1 day ago
Jutia Group

Company Update (NYSE:MRK): Merck Announces Increased Quarterly Dividend

[Business Wire] Merck , known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.45 per outstanding share of the company's common stock, up $0.01 from $0.44 ...
 Jutia Group1 day ago United States : MERCK, NewLink Genetics to team up for Ebola Vaccine [TendersInfo (India)]  Pharmacy Choice1 day ago Merck & Co submits first regulatory filing for omarigliptin, in Japan  Pharma Letter1 day ago Merck Buys Rights to Ebola Vaccine Candidate from NewLink - Analyst Blog  Zacks.com2 days ago
[x]  
Reuters

Merck Hikes Quarterly Dividend

Merck &Co. inc. (MRK: Quote) said Tuesday that its Board of Directors has increased the company's quarterly dividend to $0.45 per share, up $0.01 from $0.44 per share paid last quarter. The new dividend will be payable on January 8, 2015, to ...
 RTTNews.com2 days ago Merck declares $0.45 dividend  Seeking Alpha2 days ago Merck reports lower Q3 net income, provides annual outlook  Individual.com2 days ago Merck & Co., Inc. Announces Quarterly Dividend of $0.45 (MRK)  Ticker Report2 days ago
Bioresearch Online

Merck KGaA : Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in...

Pfizer Forms Global Strategic Alliance with Merck KGaA , Germany , to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Pfizer Inc. (NYSE:PFE) ...
 4 Traders1 day ago Merck partners with Pfizer to co-develop and co-commercialize anti-cancer drug  Individual.com6 days ago Pfizer Links With Merck KGaA In Immuno-Oncology Mega Deal  Bioresearch Online1 week ago Merck forms global alliance with Pfizer for co- developing cancer drug  Business Standard1 week ago
[x]  
Bidness Etc

Merck's acute coronary syndrome study meets primary and secondary endpoints

Merck & Co., Inc. has announced that the investigational IMPROVE-IT study for VYTORIN, in patients with acute coronary syndrome, met its primary and secondary composite efficacy endpoints. In IMPROVE-IT, patients taking the LDL-cholesterol-lowering ...
 Individual.com2 days ago Merck announces positive data from Phase II melanoma analysis  Individual.com3 days ago Anti-PD-1 Drug Keytruda Gives Merck and Co. (MRK) Reason To Rejoice Again  Bidness Etc1 week ago Merck & Co's LDL-lowering drug Vytorin meets study endpoints  Pharma Letter1 week ago
Bidness Etc

NewLink Genetics, Merck and Co. (MRK) In Talks To Scale Up Ebola Vaccine Production

Biotech NewLink and pharma giant Merck have reportedly come together to find ways to accelerate production of NewLink's experimental Ebola vaccine Page 1 of 2 Click Ticker to See live coverage NewLink Genetics Corp ( NASDAQ:NLNK ) and ...
 Bidness Etc6 days ago NewLink Said in Talks With Merck & Co. to Produce Ebola Vaccine  Washington Post6 days ago NewLink Said in Talks With Merck on Ebola Vaccine Production  Washington Post1 week ago NewLink in Talks With Merck on Producing Ebola Vaccine  FirstWord Pharma1 week ago

Merck inaugurates Biomass Plant in Goa, India

Goa: Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, commissioned a climate-neutral co-generation plant at its production site in Goa, India. In doing so, Merck ...
 Deccan Chronicle2 days ago Merck inaugurate Biomass Plant in Goa  India Infoline1 day ago

Merck : Findings from Merck & Company Broaden Understanding of Heart Failure (Comparison of clinical profile and management of outpatients with heart...

Findings from Merck & Company Broaden Understanding of Heart Failure (Comparison of clinical profile and management of outpatients with heart failure with reduced left ventricular ejection fraction treated by general practitioners and ...) By a ...
 4 Traders1 day ago Medical Breakthroughs On The Horizon For Merck  Seeking Alpha1 week ago MERCK : New Findings on Vaccines Described by Investigators at Merck & Company (Concordance assessment between a multiplexed competitive Luminex...  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less